It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and ...

Robex’s Kiniero Gold Project, Guinea, remains on track and budget for first gold pour in Q4 CY25. The Kiniero project remains LTI free (lost time injury) with 4,857,704 hours complete to 30 September ...